CME Group Inc. (CME) stock

CMENasdaqSecurity & Commodity Brokers, Dealers, Exchanges & ServicesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/3021% above fair value

$317.97+2.47 (+0.78%)

Close on Nov 13, 2026Market cap $113.81BP/E 26.1Yield 1.57%

CME ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

CME's ebitda for the twelve months ending Dec 31, 2019 was $2.75B, up 0.7% year over year. For fiscal 2025 it was $4.34B, up 7.2% from the year before. Over ten years it grew 7.4% a year on average. The highest annual figure on record is $4.34B in fiscal 2025.

Annual ebitda

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$4.34B	+7.2%
FY2024	Dec 31, 2024	$4.05B	+13.6%
FY2023	Dec 31, 2023	$3.56B	+13.0%
FY2022	Dec 31, 2022	$3.15B	+12.8%
FY2021	Dec 31, 2021	$2.79B	+0.1%
FY2020	Dec 31, 2020	$2.79B	+1.6%
FY2019	Dec 31, 2019	$2.75B	+0.7%
FY2018	Dec 31, 2018	$2.73B	+12.5%
FY2017	Dec 31, 2017	$2.42B	+4.0%
FY2016	Dec 31, 2016	$2.33B	+10.0%
FY2015	Dec 31, 2015	$2.12B	+11.4%
FY2014	Dec 31, 2014	$1.90B	+7.3%
FY2013	Dec 31, 2013	$1.77B	-3.1%
FY2012	Dec 31, 2012	$1.83B	-14.9%
FY2011	Dec 31, 2011	$2.15B	+9.6%
FY2010	Dec 31, 2010	$1.96B	+14.3%
FY2009	Dec 31, 2009	$1.72B	-0.2%
FY2008	Dec 31, 2008	$1.72B	+48.5%
FY2007	Dec 31, 2007	$1.16B	–

Quarterly ebitda

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q4 FY2019	Dec 31, 2019	$611.00M	-10.5%
Q3 FY2019	Sep 30, 2019	$726.60M	+25.3%
Q2 FY2019	Jun 30, 2019	$744.90M	+7.3%
Q1 FY2019	Mar 31, 2019	$663.90M	-13.7%
Q4 FY2018	Dec 31, 2018	$682.80M	+20.9%
Q3 FY2018	Sep 30, 2018	$580.10M	-2.4%
Q2 FY2018	Jun 30, 2018	$694.40M	+9.5%
Q1 FY2018	Mar 31, 2018	$769.00M	+22.0%
Q4 FY2017	Dec 31, 2017	$564.80M	-1.6%
Q3 FY2017	Sep 30, 2017	$594.50M	–
Q2 FY2017	Jun 30, 2017	$634.00M	–
Q1 FY2017	Mar 31, 2017	$630.30M	–
Q4 FY2016	Dec 31, 2016	$573.90M	–